BioLine RX Ltd (NASDAQ:BLRX)

0.8578
Delayed Data
As of Apr 20
 -0.0021 / -0.24%
Today’s Change
0.80
Today|||52-Week Range
1.34
-21.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization267.7K440.8K483.5K484.4K
 
 
 
 
 
 
Operating ExpensesGross Income-267.7K-440.8K-483.5K-484.4K
 
 
 
 
 
General Expenses16.8M15.7M16.1M24.9M
 
 
 
 
 
Research And Development11.5M11.1M10.8M19.2M
 
 
 
 
 
Total Operating Expenses17.1M16.2M16.6M25.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.1M-16.2M-16.6M-25.4M
 
 
 
 
 
Extraordinary Credit3.4M1.4M207.7K347.4K
 
 
 
 
 
Extraordinary Charge-105.1K0.00---127.9K
 
 
 
Interest Expense On Debt19.5K15.0K14.0K21.1K
 
 
 
 
 
Other Expenses-819.6K-91.0K-1.0K-133.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.0M-14.4M-15.9M-24.5M
 
 
 
 
 
Net Income-11.0M-14.4M-15.9M-24.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.4M51.4M56.1M90.0M
 
 
 
 
 
Shares To Calculate EPS Diluted32.4M51.4M56.1M90.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.28-$0.28-$0.27
 
 
 
 
 
EPS Diluted-$0.33-$0.28-$0.28-$0.27